Title : [The formation and significance of antibodies to interferon beta during immunomodulating treatment of multiple sclerosis].

Pub. Date : 2004

PMID : 15045868






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Patients with multiple sclerosis receiving interferon beta (IFN) may develop neutralizing anti-interferon beta antibodies (NABs). nabs interferon beta 1 Homo sapiens
2 Patients with multiple sclerosis receiving interferon beta (IFN) may develop neutralizing anti-interferon beta antibodies (NABs). nabs interferon beta 1 Homo sapiens
3 Differences of immunogenicity between the interferon beta products with regard to their structure, formulation, dose, route of administration were presented and the influence of NABs on the biological and clinical activity of IFN beta therapy was shown. nabs interferon beta 1 Homo sapiens